ARKG vs TLI
ARKG vs TLI
ARK Genomic Revolution ETF vs Western Asset Corporate Loan Fund Inc.
Quick Verdict
ARKG offers more diversification with 31 holdings.
Lower Fees: TiedHigher Returns: TiedMore Diversified: ARKG
Side-by-Side Comparison
| Metric | ARKG | TLI | Winner |
|---|---|---|---|
| Expense Ratio | 0.75% | - | |
| AUM | $1.6B | - | |
| Dividend Yield | 0.00% | - | |
| Holdings | 33 | 0 | |
| YTD Return | +53.15% | - | |
| 1Y Return | +85.59% | - | |
| 3Y Return (annualized) | +11.98% | - | |
| 5Y Return (annualized) | -11.67% | - | |
| Volatility (annualized) | 36.4% | - | |
| Max Drawdown | -83.6% | - | |
| Fund Family | Ark Invest | Western Asset Corporate Loan Fund Inc. | |
| Category | Equity | - | |
| Inception | Oct 31, 2014 | - |
ARKG vs TLI Performance
ARK Genomic Revolution ETF (ARKG) is a ETF from Ark Invest and Western Asset Corporate Loan Fund Inc. (TLI) is a ETF from Western Asset Corporate Loan Fund Inc..
Risk: Volatility and Drawdowns
Frequently Asked Questions
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.